You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Norwegian biotech company Ultimovacs took over the immunotherapy technology business of the Swedish company Immuneed AB last month. The complementary technologies of the two companies provide a platform for development of novel vaccine solutions for treatment and possibly prevention of cancerAlready a subscriber Login You have read all your…
Getinge Group’s business area Infection Control, a global leader in infection control and contamination prevention solutions, has acquired Stericool, a Turkish company specializing in low temperature sterilization, and also signed an exclusive global distribution agreement with Canadian company TSAlready a subscriber Login You have read all your free articles, to…
Stockholm-based Affibody AB announces a new collaboration with Japanese Daiichi Sankyo. The license agreement regards the use of Affibody’s proprietary Albumod platform, a platform designed to enhance the efficacy of biopharmaceuticals by extending their circulatory half-life. The technology wiAlready a subscriber Login You have read all your free articles, to…
AstraZeneca has entered into an agreement to invest in a majority equity stake in Acerta Pharma, a privately-owned biopharmaceutical company based in the Netherlands and US. The transaction provides AstraZeneca with an irreversible oral Bruton's tyrosine kinase (BTK) inhibitor, acalabrutinib (ACPAlready a subscriber Login You have read all your free…
